ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
Sanofi India Limited announced the cessation of Mr. Nakul Verma as Public Affairs & Market Access-Head. He transitions to another role within the Sanofi group effective July 31, 2026.
Mr. Rachid Ayari will resign as Whole Time Director and CFO of Sanofi India on September 30, 2026. He is transitioning to another role within Sanofi group.
Sanofi India appointed Mr. Debajit Roy as Sales & Customer Engagement Head – Diabetes, effective June 8, 2026. He joins from Glenmark Pharmaceuticals with 20 years experience.
Sanofi India Limited appointed Mr. Rahul Bhatnagar as Chairman of the Board effective April 30, 2026. He succeeds Mr. Aditya Narayan, who completed a ten-year tenure. Additionally, Independent Director Mrs. Usha Thorat's tenure concluded on April 29, 2026. These leadership changes aim to drive strategic growth and excellence in the company's healthcare mission.
Sanofi India Limited announced leadership changes effective late April 2026. Independent Directors Aditya Narayan and Usha Thorat will conclude their tenures on April 29, 2026. Consequently, Mr. Rahul Bhatnagar, currently an Independent Director, has been appointed as the new Chairman of the Board effective April 30, 2026.
Sanofi India Limited announced a leadership transition as independent directors Mr. Aditya Narayan and Mrs. Usha Thorat complete their tenures on April 29, 2026. Consequently, Mr. Rahul Bhatnagar, currently an Independent Director, has been appointed as Chairman of the Board effective April 30, 2026.